CCA
UPI

Catalyst Capital Advisors’s UROPLASTY INC-NEW UPI Stock Holding History

Catalyst Capital Advisors’s Portfolio UPI Stock Details UPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-75,821
Closed -$251K – 353
2013
Q3 		$251K Buy
+75,821
New +$212K 0.14% 212

Other funds holding UPI

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCP
Rothschild Capital Partners New York $408M AUM 25.87% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Catalyst Capital Advisors's UPI Position: Q4 2013 in Review

Catalyst Capital Advisors sold out of UROPLASTY INC-NEW (UPI) in Q4 2013, closing a stake of 75,821 shares — an estimated $251K sold.

Catalyst Capital Advisors first reported a position in UPI in Q3 2013 and held it in 1 quarter. The position peaked at $251K in Q3 2013. 32 funds tracked by Wall St. Rank hold UPI as of Q4 2013.

  • Catalyst Capital Advisors reported no remaining UROPLASTY INC-NEW position as of Q4 2013 after selling out during the quarter.
  • Catalyst Capital Advisors sold 75,821 UROPLASTY INC-NEW shares in Q4 2013, an estimated $251K.
  • Catalyst Capital Advisors first reported a position in UROPLASTY INC-NEW in Q3 2013 and held it in 1 quarter.
  • Catalyst Capital Advisors's UROPLASTY INC-NEW position peaked at $251K in Q3 2013.
  • 32 funds tracked by Wall St. Rank held UROPLASTY INC-NEW as of Q4 2013.

Based on Catalyst Capital Advisors's 13F filing for Q4 2013, filed 13 Feb 2014.